Pharmacy problems that led to the termination threat included missing medication labels, unsystematic labeling of medication and staff incompetence.
The report following the September investigation detailed several instances of patients’ safety being jeopardized, including one in which a patient went into anaphylactic shock after an incorrectly filled medication was administered. A nurse told CMS regulators that the medication had been pulled from the automated dispensing system under an erroneous name several times. Another time, the pharmacy delivered morphine at a dosage five times greater than the physician prescribed.
The hospital implemented a plan of correction that included hiring and retraining pharmacy staff. After the CMS follow-up survey, the agency said that the hospital met the Jan. 11 deadline to bring the pharmacy into compliance with federal standards.
“I want to thank everyone involved for their commitment and dedication to improvement that was required over the past several weeks to ensure we made the necessary improvements in pharmacy services which will allow us to continue providing safe pharmaceutical care services to the people of our region,” said Robert Clark, CEO of the hospital’s operator, Bristol Bay Area Health Corporation.
More articles on pharmacy:
Cancer therapy prices prevent access to treatment, WHO says
Despite controversies, J&J ranks among Fortune’s most-admired companies
Bristol-Myers swings to $1.2B profit in Q4
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.